Target intelligence / Profile preview

Neuromelanin (NM)

Target
NM
Molecular classification
Pigment, Other
01

Overview

Neuromelanin is a complex dark pigment found primarily in the catecholaminergic neurons of the substantia nigra and locus coeruleus. It functions as a natural chelator, sequestering iron and other potentially toxic metals to protect neurons from oxidative stress (Zecca et al., 2003). In neurodegenerative conditions like Parkinson's disease, the loss of neuromelanin-containing neurons is a hallmark feature, and the release of the neuromelanin-iron complex into the extracellular space can trigger chronic neuroinflammation (Zucca et al., 2017). While not a classical therapeutic target, neuromelanin is a vital imaging biomarker used to track the progression of dopaminergic neurodegeneration (Sulzer et al., 2018). Research into this area often focuses on iron chelation therapies, such as the use of deferiprone, to reduce the pro-oxidant effects associated with iron accumulation in these specific brain regions. Consequently, these iron-rich brain regions are primary areas of interest for both diagnostic imaging and disease-modifying interventions in Parkinson's disease.

Other names
Brain melaninNeuromelanin-iron complexSubstantia nigra pigment
02

Mechanism of action

Neuromelanin functions as a high-affinity chelator for transition metals, particularly iron (Fe3+), and sequesters toxic compounds like MPTP, thereby providing neuroprotection under physiological conditions (Zecca et al., 2003). However, in disease states, the breakdown of the neuromelanin-iron complex can lead to the release of redox-active iron, promoting Fenton chemistry and oxidative damage (Zucca et al., 2017).

03

Biological functions

NeuroprotectionMetal sequestrationOxidative stress modulation
04

Disease associations

Parkinson's diseaseNeurodegenerationNeurodegeneration with brain iron accumulation
05

Safety considerations

Iron dyshomeostasisNeuroinflammation upon releaseOxidative stress
06

Interacting drugs

Deferiprone

3 more in the full profile.

07

Biomarkers

Neuromelanin-sensitive MRISusceptibility-weighted imaging (SWI)Quantitative susceptibility mapping (QSM)

Beyond the preview

Go deeper on Neuromelanin (NM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuromelanin (NM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call